Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction. [electronic resource] by
- Tamagawa, Eiji
- Bai, Ni
- Morimoto, Kiyoshi
- Gray, Claire
- Mui, Tammy
- Yatera, Kazuhiro
- Zhang, Xuekui
- Xing, Li
- Li, Yuexin
- Laher, Ismail
- Sin, Don D
- Man, S F Paul
- van Eeden, Stephan F
Producer: 20080812
In:
American journal of physiology. Lung cellular and molecular physiology vol. 295
Availability: No items available.
|
|
12.
|
Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer. [electronic resource] by
- Goldman, Jonathan W
- Rosen, Lee S
- Tolcher, Anthony W
- Papadopoulos, Kyriakos
- Beeram, Muralidhar
- Shi, Peipei
- Pitou, Celine
- Bell, Robert
- Kulanthaivel, Palaniappan
- Zhang, Xuekui
- Fink, Aaron
- Chan, Edward M
- Shahir, Ashwin
- Farrington, Daphne
- Patnaik, Amita
Producer: 20190327
In:
Investigational new drugs vol. 36
Availability: No items available.
|
|
13.
|
A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. [electronic resource] by
- Soriano, Joan B
- Sin, Don D
- Zhang, Xuekui
- Camp, Pat G
- Anderson, Julie A
- Anthonisen, Nick R
- Buist, A Sonia
- Burge, P Sherwood
- Calverley, Peter M
- Connett, John E
- Petersson, Stefan
- Postma, Dirkje S
- Szafranski, Wojciech
- Vestbo, Jørgen
Producer: 20070502
In:
Chest vol. 131
Availability: No items available.
|
|
14.
|
Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. [electronic resource] by
- Sin, Don D
- Miller, Bruce E
- Duvoix, Annelyse
- Man, S F Paul
- Zhang, Xuekui
- Silverman, Edwin K
- Connett, John E
- Anthonisen, Nicholas A
- Wise, Robert A
- Tashkin, Donald
- Celli, Bartolome R
- Edwards, Lisa D
- Locantore, Nicholas
- Macnee, William
- Tal-Singer, Ruth
- Lomas, David A
Producer: 20110711
In:
American journal of respiratory and critical care medicine vol. 183
Availability: No items available.
|
|
15.
|
A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer. [electronic resource] by
- Patnaik, Amita
- Haluska, Paul
- Tolcher, Anthony W
- Erlichman, Charles
- Papadopoulos, Kyriakos P
- Lensing, Janet L
- Beeram, Muralidhar
- Molina, Julian R
- Rasco, Drew W
- Arcos, Rebecca R
- Kelly, Claudia S
- Wijayawardana, Sameera R
- Zhang, Xuekui
- Stancato, Louis F
- Bell, Robert
- Shi, Peipei
- Kulanthaivel, Palaniappan
- Pitou, Celine
- Mulle, Lynette B
- Farrington, Daphne L
- Chan, Edward M
- Goetz, Matthew P
Producer: 20161213
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22
Availability: No items available.
|